BlackRock Advisors’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,608
| Closed | -$14K | – | 3692 |
|
|
2016
Q3 | $14K | Sell |
4,608
-1,189
| -21% | -$3.61K | ﹤0.01% | 3456 |
|
|
2016
Q2 | $9K | Sell |
5,797
-6,306
| -52% | -$9.79K | ﹤0.01% | 3542 |
|
|
2016
Q1 | $45K | Buy |
12,103
+837
| +7% | +$3.11K | ﹤0.01% | 3139 |
|
|
2015
Q4 | $114K | Sell |
11,266
-5,727
| -34% | -$58K | ﹤0.01% | 2822 |
|
|
2015
Q3 | $231K | Buy |
16,993
+2
| +0% | +$27 | ﹤0.01% | 2603 |
|
|
2015
Q2 | $322K | Sell |
16,991
-1,531
| -8% | -$29K | ﹤0.01% | 2459 |
|
|
2015
Q1 | $485K | Buy |
18,522
+2,777
| +18% | +$72.7K | ﹤0.01% | 2068 |
|
|
2014
Q4 | $330K | Sell |
15,745
-96,133
| -86% | -$2.01M | ﹤0.01% | 2275 |
|
|
2014
Q3 | $3.73M | Buy |
111,878
+51,528
| +85% | +$1.72M | ﹤0.01% | 1012 |
|
|
2014
Q2 | $1.94M | Sell |
60,350
-233,642
| -79% | -$7.5M | ﹤0.01% | 1159 |
|
|
2014
Q1 | $13.6M | Buy |
293,992
+13,221
| +5% | +$611K | 0.01% | 667 |
|
|
2013
Q4 | $19.9M | Sell |
280,771
-98,393
| -26% | -$6.98M | 0.02% | 547 |
|
|
2013
Q3 | $32.5M | Buy |
379,164
+363,755
| +2,361% | +$31.2M | 0.03% | 417 |
|
|
2013
Q2 | $976K | Buy |
+15,409
| New | +$976K | ﹤0.01% | 1387 |
|